Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-033880
Filing Date
2022-09-19
Accepted
2022-09-19 21:53:52
Documents
1
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 9459
  Complete submission text file 0001140361-22-033880.txt   10852
Mailing Address C/O ROIVANT SCIENCES LTD. 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL LONDON X0 SW1Y 4L
Business Address
MANCHESTER KEITH S (Reporting) CIK: 0001244828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 221252007

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations